4-bromo-2-fluoro-1-nitrosobenzene

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-bromo-2-fluoro-1-nitrosobenzene
• 英文别名: 4-Bromo-2-fluoro-1-nitrosobenzene
• 化学式: C₆H₃BrFNO
• 分子量: 203.998
• InChiKey: AZBJPXYUHQROLY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  29.4
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  1-氟-2-亚硝基苯 在 2,6-二叔丁基-4-甲基苯酚 、 copper(ll) bromide 作用下， 以 乙腈 为溶剂， 20.0 ℃ 、101.33 kPa 条件下， 反应 2.0h， 以29%的产率得到4-bromo-2-fluoro-1-nitrosobenzene
  参考文献：
  名称：

  亚硝基卤与铜（II）卤化物的对位选择性卤化

  摘要：

  据报道，亚硝基芳烃与溴化铜（II）和氯化物的对位选择性直接溴化和氯化。在温和的反应条件下，以中等至良好的收率和高的区域选择性获得了一系列卤代芳基亚硝基化合物。另外，通过开发一锅法以获得相应的对卤代苯胺和硝基苯衍生物，证明了该方法的多功能性。

  DOI：

  10.1021/acs.orglett.5b03198

文献信息

• COMPOUNDS AND THEIR METHODS OF USE
  申请人：Praxis Precision Medicines, Inc.

  公开号：US20210355118A1

  公开（公告）日：2021-11-18

  The present invention is directed to, in part, fused heteroaryl compounds and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a voltage-gated, sodium ion channel, for example, abnormal late/persistent sodium current. Methods of treating a disease or condition relating to aberrant function of a sodium ion channel including Dravet syndrome or epilepsy are also provided herein.

  本发明部分涉及融合的杂环基化合物和组合物，用于预防和/或治疗与电压门控钠离子通道异常功能相关的疾病或症状，例如异常的晚期/持续性钠电流。本文还提供了治疗与钠离子通道异常功能相关的疾病或症状，包括德雷维特综合征或癫痫的方法。
• Bicyclic Nitrogen-containing Heterocyclic compounds for use as Stearoyl CoA Desaturase inhibitors
  申请人：Koltun Dmitry

  公开号：US20080255130A1

  公开（公告）日：2008-10-16

  The present invention discloses bicyclic nitrogen-containing heterocyclic compounds for use as inhibitors of stearoyl-CoA desaturase. The compounds are useful in treating and/or preventing various human diseases, mediated by stearoyl-CoA desaturase (SCD) enzymes, especially diseases related to abnormal lipid levels, cardiovascular disease, diabetes, obesity, oily skin conditions, metabolic syndrome, and the like.

  本发明揭示了用作硬脂酰辅酶A去饱和酶抑制剂的双环氮杂环化合物。这些化合物在治疗和/或预防由硬脂酰辅酶A去饱和酶（SCD）酶介导的各种人类疾病方面非常有用，特别是与异常脂质水平、心血管疾病、糖尿病、肥胖、油性皮肤状况、代谢综合征等相关的疾病。
• ALKYNYL ALCOHOLS AS KINASE INHIBITORS
  申请人：Chen Guoqing

  公开号：US20110086834A1

  公开（公告）日：2011-04-14

  Selected compounds are effective for prophylaxis and treatment of inflammation and inflammatory disorders, such as NIK-mediated disorders. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, inflammation and the like.

  所选化合物对于预防和治疗炎症和炎症性疾病（如NIK介导的疾病）有效。本发明涵盖新的化合物、类似物、前药和其药学上可接受的盐、制药组合物和预防和治疗涉及炎症等疾病和其他疾病或病症的方法。
• AROMATIC AND AROMATIC/HETEROAROMATIC MOLECULAR STRUCTURES WITH CONTROLLABLE ELECTRON CONDUCTING PROPERTIES
  申请人：French Roger Harquail

  公开号：US20090270627A1

  公开（公告）日：2009-10-29

  Aromatic and aromatic/heteroaromatic molecular structures with controllable electron conducting properties are derived from the incorporation of electron active substituents in selective positions.
• 2-(3-PYRIDINYL)-1H-BENZIMIDAZOLE DERIVATIVE COMPOUND AND MEDICINE CONTAINING SAME
  申请人：NIHON MEDI-PHYSICS CO., LTD.

  公开号：US20170158668A1

  公开（公告）日：2017-06-08

  Provided is a compound represented by general formula (1) or a salt thereof as well as a medicine containing the compound or the salt. In the formula, R 1 , R 2 , R 3 , R 4 , R 5 , X 1 , X 2 , and X 3 are defined.